Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling

Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling

NAD<sup>+</sup> boosting via nicotinamide riboside (NR) confers anti-inflammatory effects. However, its underlying mechanisms and therapeutic potential remain incompletely defined. Here, we showed that NR increased the expression of CC-chemokine receptor 7 (CCR7) in human M1 macrophages...

Full description

Bibliographic Details
Main Authors:	Jing Wu, Maximilian Bley, Russell S. Steans, Allison M. Meadows, Rebecca D. Huffstutler, Rong Tian, Julian L. Griffin, Michael N. Sack
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Cells
Subjects:	chemotaxis macrophage migration NAD<sup>+</sup> boosting nicotinamide riboside prostaglandin E2 SIRT3
Online Access:	https://www.mdpi.com/2073-4409/13/5/455

Similar Items

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD<sup>+</sup> by Generating Dihydronicotinamide Riboside
by: Eleonora Ciarlo, et al.
Published: (2022-07-01)

Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects
by: Ekaterina Podyacheva, et al.
Published: (2021-09-01)

Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells
by: Andrey Kropotov, et al.
Published: (2021-01-01)

Nicotinamide Riboside Regulates Chemotaxis to Decrease Inflammation and Ameliorate Functional Recovery Following Spinal Cord Injury in Mice
by: Yan Li, et al.
Published: (2024-02-01)

Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
by: Rachel S. Fletcher, et al.
Published: (2017-08-01)

Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
by: Angelique Cercillieux, et al.
Published: (2022-12-01)

Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice
by: Patrick M. Schaefer, et al.
Published: (2022-10-01)

New Crystalline Salts of Nicotinamide Riboside as Food Additives
by: Günter Schabert, et al.
Published: (2021-05-01)

Nicotinamide Riboside and Phycocyanin Oligopeptides Affect Stress Susceptibility in Chronic Corticosterone-Exposed Rats
by: Cemal Orhan, et al.
Published: (2023-10-01)

The Role of NAD<sup>+</sup> and NAD<sup>+</sup>-Boosting Therapies in Inflammatory Response by IL-13
by: Anton D. Pugel, et al.
Published: (2024-02-01)

Synthesis, Stability, and Bioavailability of Nicotinamide Riboside Trioleate Chloride
by: Amin Zarei, et al.
Published: (2021-12-01)

NAD<sup>+</sup> Precursors: A Questionable Redundancy
by: Carles Canto
Published: (2022-07-01)

Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
by: Nahid A Khan, et al.
Published: (2014-06-01)

Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment
by: Eun Seong Hwang, et al.
Published: (2020-04-01)

Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD+ precursor nicotinamide riboside
by: Sharath Anugula, et al.
Published: (2023-06-01)

Intravenous Nicotinamide Riboside Administration Has a Cardioprotective Effect in Chronic Doxorubicin-Induced Cardiomyopathy
by: Ekaterina Podyacheva, et al.
Published: (2022-10-01)

Enzymatic synthesis of high-titer nicotinamide mononucleotide with a new nicotinamide riboside kinase and an efficient ATP regeneration system
by: Xiao-Long Qian, et al.
Published: (2022-03-01)

Improving Mitochondrial Function in Skeletal Muscle Contributes to the Amelioration of Insulin Resistance by Nicotinamide Riboside
by: Qiuyan Li, et al.
Published: (2023-06-01)

Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
by: Mario Mehmel, et al.
Published: (2020-05-01)

The effects of in ovo nicotinamide riboside dose on broiler myogenesis
by: Xiaoxing Xu, et al.
Published: (2021-03-01)

Syntheses and chemical properties of β-nicotinamide riboside and its analogues and derivatives
by: Mikhail V. Makarov, et al.
Published: (2019-02-01)

Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
by: Petra Simic, et al.
Published: (2020-08-01)

How to mitigate neurological and cardiac decompensation in Leigh syndrome: Can nicotinamide riboside be an answer?
by: Alessandro Prigione, et al.
Published: (2022-09-01)

Comparison of protective effects of nicotinamide mononucleotide and nicotinamide riboside on DNA damage induced by cisplatin in HeLa cells
by: Shuting Qiu, et al.
Published: (2024-03-01)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
by: Lars Jansen Sverkeli, et al.
Published: (2021-07-01)

The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis
by: Ekaterina Podyacheva, et al.
Published: (2023-04-01)

Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration
by: Tanja Sonntag, et al.
Published: (2022-11-01)

Emerging Role of Nicotinamide Riboside in Health and Diseases
by: Chiranjeev Sharma, et al.
Published: (2022-09-01)

Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC
by: EFSA Panel on Nutrition, Novel foods and Food allergens (NDA), et al.
Published: (2019-08-01)

Nicotinamide Mononucleotide Supplementation Improves Mitochondrial Dysfunction and Rescues Cellular Senescence by NAD<sup>+</sup>/Sirt3 Pathway in Mesenchymal Stem Cells
by: Huan Wang, et al.
Published: (2022-11-01)

Nicotinamide, Nicotinamide Riboside and Nicotinic Acid—Emerging Roles in Replicative and Chronological Aging in Yeast
by: Ivan Orlandi, et al.
Published: (2020-04-01)

Structural and Functional Characterization of NadR from <i>Lactococcus lactis</i>
by: Artem Stetsenko, et al.
Published: (2020-04-01)

Extension of use of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2021-11-01)

Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular Cancer Progression in Mice
by: Nengzhi Pang, et al.
Published: (2023-03-01)

S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
by: Angela Lee, et al.
Published: (2023-11-01)

Improvement Effect of Mitotherapy on the Cognitive Ability of Alzheimer’s Disease through NAD<sup>+</sup>/SIRT1-Mediated Autophagy
by: Xiaoxi Yang, et al.
Published: (2023-11-01)

Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model
by: Ibuki Arizono, et al.
Published: (2023-08-01)

Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
by: Claudia Tovar-Palacio, et al.
Published: (2022-02-01)

Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors
by: Sei-ichi Tanuma, et al.
Published: (2020-08-01)

Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication
by: Knut H Lauritzen, et al.
Published: (2021-08-01)